DuPont to Split Into Three Companies as CEO Ed Breen Steps Back [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
Most Read from Bloomberg These Flight Routes Suffer the World's Worst Turbulence Citi Trader Got 711 Warning Messages Before Sparking Flash Crash One Dead After Singapore Air Flight Hit By Severe Turbulence Barclays Managers Warn Some Staff to Prepare for Five Days a Week in Office The company will separate its electronics and water units through tax-free transactions, DuPont announced Wednesday in a statement. The remaining operations will be focused on industries such as biopharma and medical devices, with products including Tyvek and Kevlar. Chief Executive Officer Ed Breen, who returned to the role in 2020, will step down June 1, the company said. He will retain the role of executive chairman of the remaining company while Chief Financial Officer Lori Koch assumes the CEO post. The breakup continues DuPont's lengthy history of dealmaking and portfolio reshaping. About a decade ago, the company agreed to merge with Dow Chemical and subsequently spun off some business
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- FDA tags Megadyne paediatric return electrode recall as Class I [Yahoo! Finance]Yahoo! Finance
- EU elections lurch right, risking the continent's life science stability [Yahoo! Finance]Yahoo! Finance
- TALVEY®? (talquetamab) demonstrated highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma [Yahoo! Finance]Yahoo! Finance
- TALVEY® (talquetamab-tgvs) demonstrates highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma [Yahoo! Finance]Yahoo! Finance
- TALVEY® (talquetamab-tgvs) demonstrates highly durable, longer-term responses in patients with relapsed or refractory multiple myelomaPR Newswire
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 6/6/24 - Form 4
- 6/6/24 - Form 4
- 5/28/24 - Form SD
- JNJ's page on the SEC website